Table 1. Association between prostate cancer risk and the Y-chromosomal haplogroups O-M122 and O-SRY in previous studies of the Japanese population, and in the Korean population.
| Paracchini et al. [12] | This study | |||
| O-M122 | Y*(xO-M122) | O-M122 | Y*(xO-M122) | |
| Prostate cancer | 56 (25%) | 167 (75%) | 52 (49%) | 54 (51%) |
| Normal controls | 56 (17%) | 272 (83%) | 50 (45%) | 60 (55%) |
| OR (95% CI) | 1.63 (1.07–2.47) | 1.16 (0.68–1.97) | ||
| p value | 0.02 | 0.60 | ||
| Ewis et al. [21] | This study | |||
| O-SRY | Y*(xO-SRY) | O-SRY | Y*(xO-SRY) | |
| Prostate cancer | 20 (22%) | 72 (78%) | 29 (27%) | 77 (73%) |
| Normal controls | 41 (38%) | 68 (62%) | 29 (26%) | 81 (74%) |
| OR (95% CI) | 0.46 (0.25–0.86) | 1.05 (0.58–1.92) | ||
| p value | 0.01 | 0.87 | ||
Abbreviations: CI, confidence interval; OR, odds ratio